CRAIG DANIELS to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications CRAIG DANIELS has written about Xenograft Model Antitumor Assays.
Connection Strength
0.128
-
Targeting TET3 suppresses group 3 medulloblastoma stemness and progression via impairing hypomethylation of Otx2 super-enhancer. Cell Rep Med. 2025 Dec 16; 6(12):102474.
Score: 0.048
-
Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy. Cancer Res. 2025 Oct 01; 85(19):3737-3751.
Score: 0.047
-
Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma. Nat Med. 2020 05; 26(5):720-731.
Score: 0.033